Healthcare in Metaverse Market Research Report: By Component (Software, Hardware [VR Headsets, AR Devices, Others]), By Technology (Telemedicine, Augmented Reality/ Virtual Reality/ Mixed Reality, Artificial Intelligence, Digital Twins, Blockchain, Others), By Application (Patient Engagement, Pre-Operation & Post-Operation Planning, Immersive 3D Training, 3D Lectures, VR Therapy, Remote Monitoring, Others), By End-User (Hospitals, Pharmaceutical, Insurance Companies, Others), By Region (North America, Europe, Asia-Pacific, Middle East &...
ID: MRFR/ICT/9416-HCR | August 2022 | Region: Global | 100 Pages
TABLE OF CONTENTS
1. EXECUTIVE SUMMARY
1.1. Market Attractiveness Analysis
1.1.1. Global Healthcare in Metaverse Market, by Component
1.1.2. Global Healthcare in Metaverse Market, by Technology
1.1.3. Global Healthcare in Metaverse Market, by Application
1.1.4. Global Healthcare in Metaverse Market, by End-User
1.1.5. Global Healthcare in Metaverse Market, by Region
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.3. Market Structure
3. RESEARCH METHODOLOGY
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
3.5. List of Assumptions
4. MARKET DYNAMICS
4.1. Introduction
4.2. Drivers
4.2.1. Growing Traction of Telemedicine
4.2.2. Growing Use of AR/ VR/ AI for Performing Minimal-Invasive Surgeries
4.2.3. Growing Use of Digital Twins in Healthcare
4.2.4. Driver Impact Analysis
4.3. Restraints
4.3.1. Privacy and Security Concerns in Metaverse
4.3.2. High Costs of Implementation of Technologies
4.3.3. Restraint Impact Analysis
4.4. Opportunity
4.4.1. Metaverse to Support Patients Mental Health
4.4.2. Metaverse to Revolutionize Medical Education and Training
4.4.3. Rise of Metaverse in Surgical Segments
4.5. Challenges
4.5.1. New HIPAA Guidelines for the Healthcare Metaverse
4.5.2. Adoption of Healthcare in Metaverse
4.6. Impact of COVID-19
4.6.1. Impact on Metaverse Developments
4.6.2. Covid-19 Impact on Healthcare Systems
4.6.3. Rise in Provision of Medicine as Remote Service
4.6.4. Rising Use of Telehealth during Emergence of Covid-19 Pandemic
4.7. Healthcare in Metaverse Market Trends
4.7.1. Cloud Gaming Technology for Low-Risk Medical Training
4.7.2. Digital Twin Technology
4.7.3. Medical Surgeries Through AR/ VR/ MR
4.7.4. Telemedicine Services
4.7.5. Metaverse Mental Health Treatment
4.7.6. Decentralized Communities Through Blockchain
5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis/Supply Chain Analysis
5.2. Porter’s Five Forces Model
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
6. GLOBAL HEALTHCARE IN METAVERSE MARKET, BY COMPONENT
6.1. Introduction
6.2. Software
6.3. Hardware
6.3.1. VR Headsets
6.3.2. AR Devices
6.3.3. Others
7. GLOBAL HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY
7.1. Introduction
7.2. Telemedicine
7.3. Augmented Reality/ Virtual Reality/ Mixed Reality
7.4. Artificial Intelligence
7.5. Digital Twins
7.6. Blockchain
7.7. Others
8. GLOBAL HEALTHCARE IN METAVERSE MARKET, BY APPLICATION
8.1. Introduction
8.2. Patient Engagement
8.3. Pre-Operation and Post-Operation Planning
8.4. Immersive 3D Training
8.5. 3D Lectures
8.6. VR Therapy
8.7. Remote Monitoring
8.8. Others
9. GLOBAL HEALTHCARE IN METAVERSE MARKET, BY END-USER
9.1. Introduction
9.2. Hospitals
9.3. Pharmaceutical
9.4. Insurance Companies
9.5. Others
10. GLOBAL HEALTHCARE IN METAVERSE MARKET, BY REGION
10.1. Overview
10.2. North America
10.2.1. Market Size & Estimates, by Country, 2019-2030
10.2.2. Market Size & Estimates, by Component, 2019-2030
10.2.3. Market Size & Estimates, by Technology, 2019-2030
10.2.4. Market Size & Estimates, by Application, 2019-2030
10.2.5. Market Size & Estimates, by End-User, 2019-2030
10.2.6. US
10.2.6.1. Market Size & Estimates, by Component, 2019-2030
10.2.6.2. Market Size & Estimates, by Technology, 2019-2030
10.2.6.3. Market Size & Estimates, by Application, 2019-2030
10.2.6.4. Market Size & Estimates, by End-User, 2019-2030
10.2.7. Canada
10.2.7.1. Market Size & Estimates, by Component, 2019-2030
10.2.7.2. Market Size & Estimates, by Technology, 2019-2030
10.2.7.3. Market Size & Estimates, by Application, 2019-2030
10.2.7.4. Market Size & Estimates, by End-User, 2019-2030
10.2.8. Mexico
10.2.8.1. Market Size & Estimates, by Component, 2019-2030
10.2.8.2. Market Size & Estimates, by Technology, 2019-2030
10.2.8.3. Market Size & Estimates, by Application, 2019-2030
10.2.8.4. Market Size & Estimates, by End-User, 2019-2030
10.3. Europe
10.3.1. Market Size & Estimates, by Country, 2019-2030
10.3.2. Market Size & Estimates, by Component, 2019-2030
10.3.3. Market Size & Estimates, by Technology, 2019-2030
10.3.4. Market Size & Estimates, by Application, 2019-2030
10.3.5. Market Size & Estimates, by End-User, 2019-2030
10.3.6. Germany
10.3.6.1. Market Size & Estimates, by Component, 2019-2030
10.3.6.2. Market Size & Estimates, by Technology, 2019-2030
10.3.6.3. Market Size & Estimates, by Application, 2019-2030
10.3.6.4. Market Size & Estimates, by End-User, 2019-2030
10.3.7. UK
10.3.7.1. Market Size & Estimates, by Component, 2019-2030
10.3.7.2. Market Size & Estimates, by Technology, 2019-2030
10.3.7.3. Market Size & Estimates, by Application, 2019-2030
10.3.7.4. Market Size & Estimates, by End-User, 2019-2030
10.3.8. France
10.3.8.1. Market Size & Estimates, by Component, 2019-2030
10.3.8.2. Market Size & Estimates, by Technology, 2019-2030
10.3.8.3. Market Size & Estimates, by Application, 2019-2030
10.3.8.4. Market Size & Estimates, by End-User, 2019-2030
10.3.9. Rest of Europe
10.3.9.1. Market Size & Estimates, by Component, 2019-2030
10.3.9.2. Market Size & Estimates, by Technology, 2019-2030
10.3.9.3. Market Size & Estimates, by Application, 2019-2030
10.3.9.4. Market Size & Estimates, by End-User, 2019-2030
10.4. Asia Pacific
10.4.1. Market Size & Estimates, by Country, 2019-2030
10.4.2. Market Size & Estimates, by Component, 2019-2030
10.4.3. Market Size & Estimates, by Technology, 2019-2030
10.4.4. Market Size & Estimates, by Application, 2019-2030
10.4.5. Market Size & Estimates, by End-User, 2019-2030
10.4.6. China
10.4.6.1. Market Size & Estimates, by Component, 2019-2030
10.4.6.2. Market Size & Estimates, by Technology, 2019-2030
10.4.6.3. Market Size & Estimates, by Application, 2019-2030
10.4.6.4. Market Size & Estimates, by End-User, 2019-2030
10.4.7. Japan
10.4.7.1. Market Size & Estimates, by Component, 2019-2030
10.4.7.2. Market Size & Estimates, by Technology, 2019-2030
10.4.7.3. Market Size & Estimates, by Application, 2019-2030
10.4.7.4. Market Size & Estimates, by End-User, 2019-2030
10.4.8. India
10.4.8.1. Market Size & Estimates, by Component, 2019-2030
10.4.8.2. Market Size & Estimates, by Technology, 2019-2030
10.4.8.3. Market Size & Estimates, by Application, 2019-2030
10.4.8.4. Market Size & Estimates, by End-User, 2019-2030
10.4.9. Rest of Asia-Pacific
10.4.9.1. Market Size & Estimates, by Component, 2019-2030
10.4.9.2. Market Size & Estimates, by Technology, 2019-2030
10.4.9.3. Market Size & Estimates, by Application, 2019-2030
10.4.9.4. Market Size & Estimates, by End-User, 2019-2030
10.5. Middle East & Africa
10.5.1. Market Size & Estimates, by Component, 2019-2030
10.5.2. Market Size & Estimates, by Technology, 2019-2030
10.5.3. Market Size & Estimates, by Application, 2019-2030
10.5.4. Market Size & Estimates, by End-User, 2019-2030
10.6. South America
10.6.1. Market Size & Estimates, by Component, 2019-2030
10.6.2. Market Size & Estimates, by Technology, 2019-2030
10.6.3. Market Size & Estimates, by Application, 2019-2030
10.6.4. Market Size & Estimates, by End-User, 2019-2030
11. COMPETITIVE LANDSCAPE
11.1. Introduction
11.2. Competitive Benchmarking
11.3. Metaverse Technology
11.3.1. Overview of the Metaverse Ecosystem
11.3.2. Development Stages of the Metaverse
11.3.3. Current State of the Metaverse
11.4. Key Developments & Growth Strategies
11.4.1. New Product Development
11.4.2. Mergers & Acquisitions
11.4.3. Contracts & Agreements
11.5. Key Healthcare in Metaverse Initiatives undertaken by Major Company’s
12. COMPANY PROFILES
12.1. 8chili, Inc. (US)
12.1.1. Company Overview
12.1.2. Financial Overview
12.1.3. Products/Services/Solutions Offered
12.1.4. Key Developments
12.1.5. SWOT Analysis
12.1.6. Key Strategies
12.2. Brainlab AG (Germany)
12.2.1. Company Overview
12.2.2. Financial Overview
12.2.3. Products/Services/Solutions Offered
12.2.4. Key Developments
12.2.5. SWOT Analysis
12.2.6. Key Strategies
12.3. Novarad Corporation (US)
12.3.1. Company Overview
12.3.2. Financial Overview
12.3.3. Products/Services/Solutions Offered
12.3.4. Key Developments
12.3.5. SWOT Analysis
12.3.6. Key Strategies
12.4. GE Healthcare (US)
12.4.1. Company Overview
12.4.2. Financial Overview
12.4.3. Products/Services/Solutions Offered
12.4.4. Key Developments
12.4.5. SWOT Analysis
12.4.6. Key Strategies
12.5. Siemens Healthineers (Germany)
12.5.1. Company Overview
12.5.2. Financial Overview
12.5.3. Products/Services/Solutions Offered
12.5.4. Key Developments
12.5.5. SWOT Analysis
12.5.6. Key Strategies
12.6. Meta Platforms Inc. (US)
12.6.1. Company Overview
12.6.2. Financial Overview
12.6.3. Products/Services/Solutions Offered
12.6.4. Key Developments
12.6.5. SWOT Analysis
12.6.6. Key Strategies
12.7. Nvidia Corporation (US)
12.7.1. Company Overview
12.7.2. Financial Overview
12.7.3. Products/Services/Solutions Offered
12.7.4. Key Developments
12.7.5. SWOT Analysis
12.7.6. Key Strategies
12.8. Microsoft Corporation (US)
12.8.1. Company Overview
12.8.2. Financial Overview
12.8.3. Products/Services/Solutions Offered
12.8.4. Key Developments
12.8.5. SWOT Analysis
12.8.6. Key Strategies
12.9. Roblox Corporation (US)
12.9.1. Company Overview
12.9.2. Financial Overview
12.9.3. Products/Services/Solutions Offered
12.9.4. Key Developments
12.9.5. SWOT Analysis
12.9.6. Key Strategies
12.10. Medtronic PLC (Ireland)
12.10.1. Company Overview
12.10.2. Financial Overview
12.10.3. Products/Services/Solutions Offered
12.10.4. Key Developments
12.10.5. SWOT Analysis
12.10.6. Key Strategies
12.11. Zimmer Biomet (US)
12.11.1. Company Overview
12.11.2. Financial Overview
12.11.3. Products/Services/Solutions Offered
12.11.4. Key Developments
12.11.5. SWOT Analysis
12.11.6. Key Strategies
12.12. Veyond Metaverse (US)
12.12.1. Company Overview
12.12.2. Financial Overview
12.12.3. Products/Services/Solutions Offered
12.12.4. Key Developments
12.12.5. SWOT Analysis
12.12.6. Key Strategies
12.13. gameChange VR (UK)
12.13.1. Company Overview
12.13.2. Financial Overview
12.13.3. Products/Services/Solutions Offered
12.13.4. Key Developments
12.13.5. SWOT Analysis
12.13.6. Key Strategies
12.14. Sesame Care (US)
12.14.1. Company Overview
12.14.2. Financial Overview
12.14.3. Products/Services/Solutions Offered
12.14.4. Key Developments
12.14.5. SWOT Analysis
12.14.6. Key Strategies
12.15. PlushCare (US)
12.15.1. Company Overview
12.15.2. Financial Overview
12.15.3. Products/Services/Solutions Offered
12.15.4. Key Developments
12.15.5. SWOT Analysis
12.15.6. Key Strategies
12.16. Intuitive Surgical Inc. (US)
12.16.1. Company Overview
12.16.2. Financial Overview
12.16.3. Products/Services/Solutions Offered
12.16.4. Key Developments
12.16.5. SWOT Analysis
12.16.6. Key Strategies
12.17. BioFlight VR (US)
12.17.1. Company Overview
12.17.2. Financial Overview
12.17.3. Products/Services/Solutions Offered
12.17.4. Key Developments
12.17.5. SWOT Analysis
12.17.6. Key Strategies
12.18. CAE Inc. (Canada)
12.18.1. Company Overview
12.18.2. Financial Overview
12.18.3. Products/Services/Solutions Offered
12.18.4. Key Developments
12.18.5. SWOT Analysis
12.18.6. Key Strategies
12.19. EON Reality Inc. (US)
12.19.1. Company Overview
12.19.2. Financial Overview
12.19.3. Products/Services/Solutions Offered
12.19.4. Key Developments
12.19.5. SWOT Analysis
12.19.6. Key Strategies
12.20. ImmersiveTouch Inc. (US)
12.20.1. Company Overview
12.20.2. Financial Overview
12.20.3. Products/Services/Solutions Offered
12.20.4. Key Developments
12.20.5. SWOT Analysis
12.20.6. Key Strategies
12.21. Medical Realities Ltd. (UK)
12.21.1. Company Overview
12.21.2. Financial Overview
12.21.3. Products/Services/Solutions Offered
12.21.4. Key Developments
12.21.5. SWOT Analysis
12.21.6. Key Strategies
12.22. Augmedics (US)
12.22.1. Company Overview
12.22.2. Financial Overview
12.22.3. Products/Services/Solutions Offered
12.22.4. Key Developments
12.22.5. SWOT Analysis
12.22.6. Key Strategies
12.23. Aimedis B.V. (Belgium)
12.23.1. Company Overview
12.23.2. Financial Overview
12.23.3. Products/Services/Solutions Offered
12.23.4. Key Developments
12.23.5. SWOT Analysis
12.23.6. Key Strategies
12.24. ARBREA LABS (Switzerland)
12.24.1. Company Overview
12.24.2. Financial Overview
12.24.3. Products/Services/Solutions Offered
12.24.4. Key Developments
12.24.5. SWOT Analysis
12.24.6. Key Strategies
12.25. Wellx.ai (Dubai)
12.25.1. Company Overview
12.25.2. Financial Overview
12.25.3. Products/Services/Solutions Offered
12.25.4. Key Developments
12.25.5. SWOT Analysis
12.25.6. Key Strategies
 
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS
TABLE 2 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 3 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 4 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 5 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 6 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY REGION, 2019-2030 (USD MILLION)
TABLE 7 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
TABLE 8 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 9 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 10 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 11 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 12 US: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 13 US: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 14 US: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 15 US: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 16 CANADA: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 17 CANADA: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 18 CANADA: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 19 CANADA: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 20 MEXICO: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 21 MEXICO: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 22 MEXICO: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 23 MEXICO: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 24 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
TABLE 25 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 26 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 27 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 28 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 29 UK: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 30 UK: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 31 UK: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 32 UK: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 33 GERMANY: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 34 GERMANY: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 35 GERMANY: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 36 GERMANY: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 37 FRANCE: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 38 FRANCE: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 39 FRANCE: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 40 FRANCE: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 41 REST OF EUROPE: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 42 REST OF EUROPE: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 43 REST OF EUROPE: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 44 REST OF EUROPE: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 45 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
TABLE 46 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 47 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 48 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 49 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 50 CHINA: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 51 CHINA: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 52 CHINA: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 53 CHINA: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 54 JAPAN: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 55 JAPAN: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 56 JAPAN: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 57 JAPAN: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 58 INDIA: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 59 INDIA: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 60 INDIA: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 61 INDIA: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 62 REST OF ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 63 REST OF ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 64 REST OF ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 65 REST OF ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 66 MIDDLE EASE & AFRICA: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 67 MIDDLE EASE & AFRICA: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 68 MIDDLE EASE & AFRICA: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 69 MIDDLE EAST & AFRICA: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
TABLE 70 SOUTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
TABLE 71 SOUTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
TABLE 72 SOUTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
TABLE 73 SOUTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
 
 
LIST OF FIGURES
FIGURE 1 MARKET SYNOPSIS
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 TOP DOWN & BOTTOM-UP APPROACH
FIGURE 4 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
FIGURE 5 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
FIGURE 6 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
FIGURE 7 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
FIGURE 8 GLOBAL HEALTHCARE IN METAVERSE MARKET, BY REGION, 2019-2027 (USD MILLION)
FIGURE 9 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
FIGURE 10 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
FIGURE 11 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
FIGURE 12 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
FIGURE 13 NORTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
FIGURE 14 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
FIGURE 15 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
FIGURE 16 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
FIGURE 17 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
FIGURE 18 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2030 (USD MILLION)
FIGURE 19 EUROPE: HEALTHCARE IN METAVERSE MARKET, BY REGION, 2019-2027 (USD MILLION)
FIGURE 20 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY COUNTRY, 2019-2030 (USD MILLION)
FIGURE 21 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
FIGURE 22 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
FIGURE 23 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
FIGURE 24 ASIA-PACIFIC: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2027 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
FIGURE 26 MIDDLE EAST & AFRICA: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
FIGURE 27 MIDDLE EAST & AFRICA: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST & AFRICA: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2027 (USD MILLION)
FIGURE 29 SOUTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY COMPONENT, 2019-2030 (USD MILLION)
FIGURE 30 SOUTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY TECHNOLOGY, 2019-2030 (USD MILLION)
FIGURE 31 SOUTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY APPLICATION, 2019-2030 (USD MILLION)
FIGURE 32 SOUTH AMERICA: HEALTHCARE IN METAVERSE MARKET, BY END-USER, 2019-2027 (USD MILLION)
Healthcare in Metaverse Market
Healthcare in metaverse market is expected to grow USD 5,373. Million at a CAGR of ~48.3% during the forecast 2024–2030.
$5,373. Million
Market Size
48.3%%
CAGR
North America
Dominating Region
2024-2030
Forecast Period
Segmentation
Key Players
- 8chili Inc (US)
- Brainlab AG (Germany)
- Novarad Corporation (US)
- GE Healthcare (US)
- Siemens Healthineers (Germany)
- Meta Platforms Inc (US)
- Nvidia Corporation (US)
- Microsoft Corporation (US)
- Roblox Corporation (US)
- Medtronic PLC (Ireland)
- Zimmer Biomet (US)
- Veyond Metaverse (US)
- gameChange VR (UK)
- Sesame Care (US)
- PlushCare (US)
- Intuitive Surgical Inc (US)
- BioFlight VR (US)
- CAE Inc (Canada)
- EON Reality Inc (US)
- ImmersiveTouch Inc (US)
- Medical Realities Ltd (UK)
- Augmedics (US)
- Aimedis BV (Belgium)
- ARBREA LABS (Switzerland)
Drivers
- Growing Use of Digital Twins in Healthcare
Healthcare in Metaverse Market Synopsis
The metaverse, like telemedicine and mobile device integration before it, has the potential to be a significant technological gamechanger in healthcare. The metaverse's potential is astounding since it combines virtual reality (VR) and augmented reality (AR) technologies to function in virtual spaces: All evidence led to broad adoption of the metaverse as a disruptive shift in healthcare, including better surgical precision, therapeutic utilization, social-distancing accommodations, and more.
The metaverse is a parallel world or visual depiction of reality, but it is not augmented reality (AR), virtual reality (VR), or mixed reality (MR), but rather a hybrid of these technologies that adds artificial intelligence. The metaverse is the result of the convergence of these three main technology trends, each of which has the potential to affect healthcare in its own way. Together, though, they have the potential to develop totally new channels for delivering treatment, potentially lowering costs and significantly improving patient outcomes. Telepresence (enabling individuals to be together digitally even while they are physically separated), digital twinning, and blockchain are a few examples (and its ability to let us create a distributed internet). Nonetheless, with these advancements come new problems that will reshape modern healthcare as we know it. The metaverse represents a paradigm shift in healthcare that stakeholders must be aware of, from ensuring seamless integration across current medical infrastructure to balancing starting costs and data security/privacy problems.
The metaverse, also known as the Internet 3.0, is an advancement in how people may socially engage with one another despite geographical distance and regional barriers. The Metaverse is poised to usher in a disruptive revolution in many areas of life, including healthcare. For many decades, healthcare delivery required physical interaction between a patient and a doctor in order to make a diagnosis, receive medical treatment, or perform surgical procedures, among other things; this has changed significantly with the introduction of telehealth services, which have become a part of the patient-doctor interaction via digital means and the Internet. However, with AR and VR technology enabling previously imagined possibilities, digital health solutions are on the cusp of becoming unprecedentedly bigger and more voluminous.
According to Market Research Future, the global healthcare in metaverse market is expected to grow from 504.8 million in 2024 to 5,373 Million by 2030 and register a staggering CAGR of 48.3% during the forecast, 2024 to 2030.
Global Healthcare in Metaverse Market, 2019–2030 (USD Billion)
Source: MRFR Analysis
COVID-19 Analysis
The COVID-19 epidemic has left its mark on almost every industry on the planet. Consequently, the impact on the healthcare sector is significant. Telemedicine — the supply of medication as a remote service – has grown in prominence in healthcare amid the Covid-19 epidemic. Prior to 2020, just 43% of healthcare facilities could give remote therapy to patients. Today, that percentage is 95 percent. For routine consultations that do not require a physical examination (or can be performed visually), physicians and nurses have discovered that they can diagnose many of the minor ailments that make up the vast majority of their caseload via phone or video call more swiftly and efficiently. This will very certainly continue in the metaverse. However, virtual reality — a fundamental technology that permits the next-level immersion that classifies a platform or application as part of the metaverse – offers up an entirely new set of possibilities. Anyone who has tried it knows that headset-based virtual reality experiences provide a significantly higher sensation of "being there" than other virtual environments such as webpages, messaging applications, or social media.
Healthcare in Metaverse Market Dynamics
The expanding popularity of telemedicine, the usage of AR/VR/AI for performing minimal-invasive procedures, and the growing use of digital twins in healthcare are just a few of the factors driving the growing interest in the healthcare in metaverse market. Furthermore, the capacity to assist mental health within the metaverse, as well as transform medical education and training with immersive 3D applications, and the emergence of metaverse in surgical sectors, emphasise the expanding benefits of healthcare in metaverse market. Whereas growing concerns about privacy and security, as well as the exorbitant cost of implementing new technology, are hindering industry growth. Furthermore, adjusting business models to new HIPAA requirements for the healthcare metaverse, as well as user uptake of healthcare in metaverse market, provide industry obstacles.
Healthcare in Metaverse Market Driver
- Growing Use of Digital Twins in Healthcare
In medical, digital twins may collect vast volumes of patient scan data (MRI, CT, ultrasound scans) over time and combine it into a single perspective to plan procedures and track disease development and therapy. Prototypes and reproductions of the human body, hospital systems, or complete hospitals are already in operation in many circumstances. EMPA (Swiss Federal Laboratories for Materials Science and Technology) researchers, for example, have already constructed several hundred avatars of actual patients suffering from chronic pain and are using them to optimize and forecast the impact of pharmaceuticals. The use of digital twins in healthcare is transforming clinical operations and hospital administration by improving medical treatment through digital tracking and human body modelling. Individual patients, for example, might benefit from "digital twins" of organs such as the heart or even single cells. Then, simulations may be run to see how different people react to different treatments. However, digital twin technology may also be used to represent an individual's genes, physiological traits, and lifestyle in order to fully tailor therapy. A digital twin of a human body can help physicians detect disease before symptoms appear, experiment with therapies, and better prepare for surgery.
Healthcare in Metaverse Market Opportunity
- Metaverse to Support Patients Mental Health
The metaverse poses intriguing mental health problems, such as addiction to virtual worlds, harming persons suffering from mental diseases such as psychosis, schizophrenia, sadness, or anxiety, and revolutionizing mental health therapy entirely. Metaverse in mental health can be used to treat phobias, PTSD, anxiety disorders, hallucinations, and delusions, among other things. During a mental breakdown, technology has revolutionised the way we seek help from friends, family, coworkers, or healthcare experts. Companies in the virtual reality field are developing mental health applications for the metaverse since this technology has the potential to improve human well-being. For example, in February 2022, Dr Lisa Cortez, nicknamed The Anxiety Dr, announced the debut of the Moody Minks, an NFT line aimed at bringing mental wellness to the metaverse. Moody Mink Society will house the first META-tation centre, and NFT holders will have access to The Anxiety Dr.'s programmes. Visitors to the metaverse can engage with one another via playing games, attending virtual events, and visiting galleries.
RESTRAINT
- Privacy and Security Concerns in Metaverse
In the Metaverse, patients' personal information is also an issue. When merging the Metaverse into healthcare, additional challenges must be addressed. Due to the fact that hackers usually target high-value and vulnerable targets. Furthermore, as the volume of patient data increases, so does the necessity to secure the privacy of that data. It's too soon to say whether patients feel comfortable speaking and interacting with the Metaverse on a big scale, but first findings are promising.
The Metaverse is emerging as an interactive virtual technology with the potential to improve patient care throughout the whole healthcare spectrum. Regardless, the Metaverse's numerous new changing dimensions will bring issues that shareholders must be aware of. In summary, if healthcare anticipates these possible hazards, it will be better prepared for this aesthetically attractive technology.
Segmentation
The global Healthcare in Metaverse market has been segmented based on component, technology, application, end-user, and region.
Based on component, the healthcare in metaverse market has been segmented into software and hardware. The hardware segment is further bifurcated into VR headset, AR devices, among others.
Based on technology, the market has been segmented into telemedicine, augmented reality/ virtual reality/ mixed reality, artificial intelligence, digital twins, blockchain among others.
Based on application, the healthcare in metaverse market is segmented into patient engagement, pre-operation and post-operation planning, immersive 3D training, 3D lectures, VR therapy, remote monitoring, among others.
Based on end-user, the market has been segmented into hospitals, pharmaceuticals, insurance companies, and others.
The global healthcare in Metaverse market has been analyzed for five regions—North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
Healthcare in Metaverse Market Regional Analysis
The geographic analysis of the global Healthcare in Metaverse market has been conducted for North America, Europe, Asia-Pacific, the Middle East & Africa, and South America.
North America is predicted to contribute the most to the metaverse business. This area consists of the United States, Canada, and Mexico. The most important driver driving market growth is the rising emphasis on integrating digital and physical worlds through the internet, as well as the increased traction and popularity of mixed reality (MR). Many businesses in North America are heavily utilising sophisticated virtual reality, 3D simulation, and augmented reality to improve their company processes. Technologies such as Extended Reality, 5G, and AI may make the metaverse futuristic from the standpoint of corporate intelligence.
The Asia-Pacific metaverse market is predicted to grow at the fastest rate due to the increased usage of the internet and other technologies to bring the digital and physical worlds closer together. Mixed reality is gaining pace and appeal for boosting the use of skills growing diverse trends across several firms in China, Japan, and India, in order to make data-driven business choices. The growing necessity among regional businesses to compete with their western counterparts has fueled the region's use of metaverse solutions.
Healthcare in Metaverse Market Competitive Analysis
The global Healthcare in Metaverse market is witnessing a high growth mainly due to rising expending power among individuals, rapid adoption of technologies to design & develop the software/ solutions, and surging demand for Healthcare in Metaverse. Major players have opted for partnerships, collaborations, acquisitions, and product developments as their key organic growth strategies to enhance their positions in the market and cater to the demands of healthcare in the metaverse across various industry end-users.
Key Developments
- In February 2022, Alo Yoga announced the launch of the virtual 'Alo Sanctuary,' an immersive health area for yoga and meditation, in conjunction with Roblox. More and more people are projected to enhance their fitness and health journey with VR-based exercise as awareness and purchasing power grow
- In January 2022, ImmersiveTouch, a prominent medical technology business establishing the digital surgery metaverse, has installed revolutionary digital surgery technology at the All India Institutes of Medical Sciences (AIIMS) in New Delhi. Its Mission Rehearsal VR tool enables surgeons to design and recreate each patient's unique anatomy in 3D before entering the operation room. ImmersiveTouch's Mission Rehearsal® VR platform turns 2D data into a digital twin of the patient, giving surgeons unimpeded views of the target anatomy from every aspect and access to high-fidelity surgical planning tools with pinpoint precision.
- Neurosurgeons at Johns Hopkins have performed the institution's first augmented reality operations on living patients. In June 2020, six screws were put in a patient's spine for spinal fusion surgery to fuse three vertebrae in order to treat the patient's persistent, painful back pain. In June 2020, physicians performed a second operation to remove a malignant growth known as a chordoma from a patient's spine. Both patients are doing well after surgery, according to the physicians. The physicians employed augmented reality surgery equipment that included a headset with a see-through eye display that projected pictures of the patient's interior anatomy, such as bones and other tissue, based on CT scans — basically giving the surgeons X-ray vision. Augmedics, an Israeli firm, manufactures the gadget utilised in the procedures at Johns Hopkins.
Research Projects Towards the Healthcare in Metaverse
Alliance for Logistics Innovation Through Collaboration in Europe (ALICE)
The European Technology Platform (ETP) Alliance for Logistics Innovation via Collaboration in Europe (ALICE) was established to provide a comprehensive strategy for logistics and supply chain management invention research, innovation, and market deployment in Europe. ALICE is founded on the understanding of the need for a unified perspective on logistics and supply chain planning and management, in which shippers and logistics service providers work closely together to achieve effective logistics and supply chain operations. ALICE has published a thorough roadmap for the Healthcare in Metaverse. The roadmap shows significant milestones, essential technologies, and initial implementation prospects for the PI from 2020 to 2040. Advanced trial implementations of the Physical Internet idea are predicted to be operational and prevalent in industry practice by 2030, contributing to a 30% decrease in transportation congestion, pollution, and energy consumption.
Key Players
The key players in the global Healthcare in metaverse market are 8chili Inc. (US), Brainlab AG (Germany), Novarad Corporation (US), GE Healthcare (US), Siemens Healthineers (Germany), Meta Platforms Inc. (US), Nvidia Corporation (US), Microsoft Corporation (US), Roblox Corporation (US), Medtronic PLC (Ireland), Zimmer Biomet (US), Veyond Metaverse (US), gameChange VR (UK), Sesame Care (US), PlushCare (US), Intuitive Surgical Inc. (US), BioFlight VR (US), CAE Inc. (Canada), EON Reality Inc. (US), ImmersiveTouch Inc. (US), Medical Realities Ltd. (UK), Augmedics (US), Aimedis B.V. (Belgium), ARBREA LABS (Switzerland), and Wellx.ai (Dubai), among others.
Intended Audience
- Value-Added Resellers (VARs)
- Healthcare Technology Company
- Digital Healthcare Providers
- Technology consultants
- Investors and venture capitalists
- Chief financial officers
- Healthcare Software Vendors/ Developers
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 5,373. Million |
| CAGR | 48.3% |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Historical Data | 2020 |
| Forecast Units | (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Component, Technology, Application |
| Geographies Covered | North America, Europe, Aisa Pacific |
| Key Vendors | 8chili Inc. (US), Brainlab AG (Germany), Novarad Corporation (US), GE Healthcare (US), Siemens Healthineers (Germany), Meta Platforms Inc. (US), Nvidia Corporation (US), Microsoft Corporation (US), Roblox Corporation (US), Medtronic PLC (Ireland), Zimmer Biomet (US), Veyond Metaverse (US), gameChange VR (UK), Sesame Care (US), PlushCare (US), Intuitive Surgical Inc. (US), BioFlight VR (US), CAE Inc. (Canada), EON Reality Inc. (US), ImmersiveTouch Inc. (US), Medical Realities Ltd. (UK), Augmedics (US), Aimedis B.V. (Belgium), ARBREA LABS (Switzerland), and Wellx.ai (Dubai), among others. |
| Key Market Opportunities | Metaverse to Support Patients Mental Health |
| Key Market Drivers | Growing Use of Digital Twins in Healthcare |
